Opinion

First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines

From COVID-19 vaccines to Moderna’s mRNA flu vaccine, using mRNA as medicine has shown promise. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases…

August 6, 2026 1 min read Pressivio News Desk

Source: The Conversation

First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines — Image via The Conversation.

PRESSIVIO NEWS BRIEF · OPINION

Pressivio’s Opinion desk has added the source report “First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines” to its international monitoring stream.

From COVID-19 vaccines to Moderna’s mRNA flu vaccine, using mRNA as medicine has shown promise. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases to treat.

Original source: The Conversation
Read the full report at The Conversation →

This page is a concise, attributed news-monitoring brief. Reporting, quotations and supporting material remain with the original publisher.

Related coverage

More from Opinion